Supernus Pharmaceuticals
SUPN
#3900
Rank
โ‚ฌ2.66 B
Marketcap
46,41ย โ‚ฌ
Share price
-0.74%
Change (1 day)
57.16%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: โ‚ฌ2.66 Billion

As of March 2026 Supernus Pharmaceuticals has a market cap of โ‚ฌ2.66 Billion. This makes Supernus Pharmaceuticals the world's 3900th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ2.66 B5.93%
2025โ‚ฌ2.51 B27.59%
2024โ‚ฌ1.97 B37.94%
2023โ‚ฌ1.43 B-20.44%
2022โ‚ฌ1.79 B31.28%
2021โ‚ฌ1.36 B26.62%
2020โ‚ฌ1.08 B-2.78%
2019โ‚ฌ1.11 B-26.78%
2018โ‚ฌ1.51 B-10.77%
2017โ‚ฌ1.70 B43.17%
2016โ‚ฌ1.18 B97.42%
2015โ‚ฌ0.60 B105.39%
2014โ‚ฌ0.29 B34.35%
2013โ‚ฌ0.21 B31.52%
2012โ‚ฌ0.16 B

End of Day market cap according to different sources

On Mar 7th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

โ‚ฌ2.66 Billion
by Nasdaq info icon info icon
โ‚ฌ2.66 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ499.08 B 18,617.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ164.00 B 6,050.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ763.57 B 28,536.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ105.77 B 3,866.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
โ‚ฌ1.29 B-51.53%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
โ‚ฌ18.05 B 577.06%๐Ÿ‡บ๐Ÿ‡ธ USA